These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Omalizumab is effective in nonautoimmune urticaria. Ferrer M; Gamboa P; Sanz ML; Goikoetxea MJ; Cabrera-Freitag P; Javaloyes G; Berroa F; Kaplan AP J Allergy Clin Immunol; 2011 May; 127(5):1300-2. PubMed ID: 21315432 [No Abstract] [Full Text] [Related]
47. Development of angio-oedema after omalizumab injections in a patient with chronic spontaneous urticaria. Magen E; Chikovani T Clin Exp Dermatol; 2018 Oct; 43(7):825. PubMed ID: 29777532 [No Abstract] [Full Text] [Related]
48. Clinical utility of testing for autoimmunity in chronic idiopathic urticaria. Lapolla W; Desai N; English JC J Am Acad Dermatol; 2012 Mar; 66(3):e83-8. PubMed ID: 21565421 [TBL] [Abstract][Full Text] [Related]
49. Spontaneous (Autoimmune) Chronic Urticaria in Children: Current Evidences, Diagnostic Pitfalls and Therapeutic Management. Poddighe D; De Amici M; Marseglia GL Recent Pat Inflamm Allergy Drug Discov; 2016; 10(1):34-39. PubMed ID: 26899967 [TBL] [Abstract][Full Text] [Related]
50. Mechanisms of autoimmune activation of basophils in chronic urticaria. Kikuchi Y; Kaplan AP J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085 [TBL] [Abstract][Full Text] [Related]
51. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Metz M; Bergmann P; Zuberbier T; Maurer M Allergy; 2008 Feb; 63(2):247-9. PubMed ID: 18186820 [No Abstract] [Full Text] [Related]
52. Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria. Gericke J; Metz M; Ohanyan T; Weller K; Altrichter S; Skov PS; Falkencrone S; Brand J; Kromminga A; Hawro T; Church MK; Maurer M J Allergy Clin Immunol; 2017 Mar; 139(3):1059-1061.e1. PubMed ID: 27838346 [No Abstract] [Full Text] [Related]
53. Allergic skin diseases. Fox RW J Fla Med Assoc; 1996; 83(6):394-7. PubMed ID: 8752365 [No Abstract] [Full Text] [Related]
54. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Metz M; Altrichter S; Ardelean E; Kessler B; Krause K; Magerl M; Siebenhaar F; Weller K; Zuberbier T; Maurer M Int Arch Allergy Immunol; 2011; 154(2):177-80. PubMed ID: 20733327 [TBL] [Abstract][Full Text] [Related]
58. Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema. Maurer M; Sofen H; Ortiz B; Kianifard F; Gabriel S; Bernstein JA J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1056-1063. PubMed ID: 27911016 [TBL] [Abstract][Full Text] [Related]
59. Severe angioedema and urticaria related to thyroid antigenicity. Raza SA; Salam Z; Blank RD; Jaume J; Drezner MK Endocr Pract; 2004; 10(5):445-7. PubMed ID: 15760794 [No Abstract] [Full Text] [Related]
60. Chronic urticaria and thyroid auto-immunity. Palma-Carlos AG; Palma-Carlos ML Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):143-6. PubMed ID: 15916015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]